Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel in Recurrent/Refractory Ovarian and Peritoneal Cancer
NCT00004037Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Jun 1998
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of docetaxel in ovarian cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jun 1998; status: terminated.
02
Drugs
docetaxel
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00004037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004037.